• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

PLoS One . Community-based COVID-19 active case finding and rapid response in the Democratic Republic of the Congo: Improving case detection and res

tetano

Editor, Senior Moderator
PLoS One


. 2023 May 18;18(5):e0278251.
doi: 10.1371/journal.pone.0278251. eCollection 2023. Community-based COVID-19 active case finding and rapid response in the Democratic Republic of the Congo: Improving case detection and response

John Otokoye Otshudiema[SUP] 1 [/SUP], Gervais Léon Tengomo Folefack[SUP] 1 [/SUP], Justus M Nsio[SUP] 2 [/SUP], Cathy H Kakema[SUP] 1 [/SUP], Luigino Minikulu[SUP] 2 [/SUP], Aimé Bafuana[SUP] 2 [/SUP], Joel B Kosianza[SUP] 1 [/SUP], Antoine K Mfumu[SUP] 1 [/SUP], Edith Nkwembe[SUP] 3 [/SUP], Yannick Munyeku-Bazitama[SUP] 3 [/SUP], Sheila Makiala-Mandanda[SUP] 3 [/SUP], Noé Guinko[SUP] 1 [/SUP], Gisèle Mbuyi[SUP] 2 [/SUP], Jean-Marie K Tshilumbu[SUP] 1 [/SUP], Guy N Saidi[SUP] 1 [/SUP], Moreau-Serge Umba-di-Masiala[SUP] 1 [/SUP], Amos K Ebondo[SUP] 1 [/SUP], Jean-Jacques Mutonj[SUP] 1 [/SUP], Serge Kalombo[SUP] 1 [/SUP], Jad Kabeya[SUP] 1 [/SUP], Taty K Mawanda[SUP] 1 [/SUP], Faustin N Bile[SUP] 1 [/SUP], Gaby K Kasereka[SUP] 1 [/SUP], Placide Mbala-Kingebeni[SUP] 3 [/SUP], Steve Ahuka-Mundeke[SUP] 3 [/SUP], Humphrey Cyprian Karamagi[SUP] 4 [/SUP], Karl Njuwa Fai[SUP] 5 [/SUP], Amédée Prosper Djiguimde[SUP] 1 [/SUP]



Affiliations
Abstract

A community-based coronavirus disease (COVID-19) active case-finding strategy using an antigen-detecting rapid diagnostic test (Ag-RDT) was implemented in the Democratic Republic of Congo (DRC) to enhance COVID-19 case detection. With this pilot community-based active case finding and response program that was designed as a clinical, prospective testing performance, and implementation study, we aimed to identify insights to improve community diagnosis and rapid response to COVID-19. This pilot study was modeled on the DRC's National COVID-19 Response Plan and the COVID-19 Ag-RDT screening algorithm defined by the World Health Organization (WHO), with case findings implemented in 259 health areas, 39 health zones, and 9 provinces. In each health area, a 7-member interdisciplinary field team tested the close contacts (ring strategy) and applied preventive and control measures to each confirmed case. The COVID-19 testing capacity increased from 0.3 tests per 10,000 inhabitants per week in the first wave to 0.4, 1.6, and 2.2 in the second, third, and fourth waves, respectively. From January to November 2021, this capacity increase contributed to an average of 10.5% of COVID-19 tests in the DRC, with 7,110 positive Ag-RDT results for 40,226 suspected cases and close contacts who were tested (53.6% female, median age: 37 years [interquartile range: 26.0-50.0)]. Overall, 79.7% (n = 32,071) of the participants were symptomatic and 7.6% (n = 3,073) had comorbidities. The Ag-RDT sensitivity and specificity were 55.5% and 99.0%, respectively, based on reverse transcription polymerase chain reaction analysis, and there was substantial agreement between the tests (k = 0.63). Despite its limited sensitivity, the Ag-RDT has improved COVID-19 testing capacity, enabling earlier detection, isolation, and treatment of COVID-19 cases. Our findings support the community testing of suspected cases and asymptomatic close contacts of confirmed cases to reduce disease spread and virus transmission.


 
Back
Top Bottom